Ruby Lin Email & Phone Number

Sydney, Nsw, Au

Westmead, Nsw, Au

Adjunct Professor Ruby Lin is the Deputy Director for Science and biotechnology at Phage Australia – a program that builds on Phage Australia’s international leadership in phage therapy, microbiology, clinical and laboratory medicine, genomics, informatics and biotechnology. https://www.phageaustralia.orgIn 2017-9, Dr Lin led the Westmead Bacteriophage Therapy Team, as project manager and scientific lead to successfully demonstrate safety and feasibility of first-in-human-GMP-phage clinical trial. Furthermore, her team produced > 8 high profile papers and reviews on phage therapy in the last 5 years including being featured on Channel 7 news, ABC radio, podcast in Med J Australia, featured blog in Phage Directory and Nature Microbiology, ABC 7.30 report and several media releases. Dr Lin was instrumental in introducing therapeutic monitoring of immune gene expression responses in patients receiving phage therapy. This led to a US and an Europe filing of a patent (co-inventor Prof Jon Iredell). She has led and published >90 peered review papers, white papers and news articles (H-index of 36) many are highly cited and featured in the media. During the last 2 years, she oversees phage purification program in partnership with UNSW to explore sovereign manufacturing of therapeutic phages in Australia. This has led to implementation of locally produced phage to treat patients under a nationally approved standardised treatment and monitoring protocol to assess safety and tolerability of phage therapy for adults and paediatric patients – a world first. As deputy director of Phage Australia, Dr Lin focuses on the biobanking arm that addresses phage matching, genomic characterisation, phage and pathogen biobanking, and data informatics, as well as business development and commercialisation. She manages international stakeholders of phage collections to establish a Phage Exchange Program, as well as establishing different streams of income for Phage Australia.

Westmead, Nsw, Au

Stakeholders engagement and partnership at university, government (state and federal) and industry level.

Westmead, Nsw, Au

Adj Prof Ruby Lin is the Genomics chair of a team that is part of the Scientific Advisory Committees for the Westmead Research Precinct - 2 major teaching hospitals and 3 MRIs plus other clinical service providers. Voluntary. The SAC Genomics provide consult and strategy on capabilities and infrastructures for genomics and genomic technologiesDr Lin believes her research impact includes mentoring and serving the research community. She was past president, immediate past VP and current managing executive of Australasian Genomic Technologies Association – a premier genomic association in Australasia, and the Genomic Chair of the Scientific Advisory Committee of Westmead Precinct Hub (2 teaching hospitals and 3 Medical Research Institutes). She is a GEDI (Gender Equality, Diversity and Inclusion) committee member of AAMRI (Association of Australian Medical Research Institutes), part of STEM Women (Australian Academy of Science) and advocates for girls and women in STEMM, and she does pro bono career coaching. She is on the Phage Futures Advisory Board, Convenor of AGTA2022 and part of organising committee for International Genetics Congress 2023 Melbourne and co-convenor for International Society for Viruses of Microorganisms 2024 Cairns, Australia.

Westmead, Nsw, Au

Dr Lin works closely with key stakeholders in industry and many government organisations including NSW Health. She was instrumental in securing seed funding for NSW Pathogen Biobank, as well as Phage Biobank for the Westmead Research Hub. In 2017-9, Dr Lin led the Westmead Bacteriophage Therapy Team, as project manager and scientific lead to successfully demonstrate safety and feasibility of first-in-human-GMP-phage clinical trial. Furthermore, her team produced > 8 high profile papers and reviews on phage therapy in the last 5 years including being featured on Channel 7 news, ABC radio, podcast in Med J Australia, featured blog in Phage Directory and Nature Microbiology, ABC 7.30 report and several media releases. Dr Lin was instrumental in introducing therapeutic monitoring of immune gene expression responses in patients receiving phage therapy. This led to a US and an Europe filing of a patent (co-inventor Prof Jon Iredell). She has led and published high impact work (>90 peered review papers, white papers and news articles, H-index of 36), many are highly cited and featured in the media.

Sydney, New South Wales (Nsw), Au

Honorary position, academic and industry partnership and mentoring

Sydney, New South Wales (Nsw), Au

Honorary position. Mentoring. Collaborations. Foster research and industry partnership. Writing grants

Sydney, New South Wales (Nsw), Au

An honorary position for contribution towards teaching and collaborations with students and staff at UNSW. I give guest lectures through School of Medical Sciences and in the past decade or so, through School of Biotechnology and Biomolecular Sciences. I have strong collaborative ties with various research groups at UNSW. I am also an avid supporter of Women in Research at UNSW and am registered as a mentor through their program to support women in STEM.

Sydney, New South Wales (Nsw), Au

An honorary position where I did voluntary teaching and mentoring students and scientists through the Ramaciotti Centre for Genomics. In particular, I troubleshoot and consult projects involving microRNA microarrays, gene microarrays, Fluidigm, RNA extraction from tissues and cell cultures, next generation sequencing and experimental design. Through this network, I have been an invited guest lecturer at UTS, Sydney, UNSW and Macquarie University. I was heavily involved in genomic technologies seminars (as speaker and organiser), workshops and mentoring next generation of scientists.

Sydney, New South Wales (Nsw), Au

I was a senior research fellow based at the Ramaciotti Centre for Genomics. My research interests during this fellowship have expanded from cardiovascular disease and transcriptomics to systems biology and non-coding RNA species other than microRNA. At the start of this fellowship, I was awarded an NHMRC project grant with A/Prof Julie McMullen to look at transcriptomics of myocardial infarction in a PI3K mouse model. During this fellowship, I have had two of my own functional genomics experiments that resulted in 8 months of maternity leave with my first child and 1 year of maternity leave with my second. Despite the lengthy break, I managed to secure another NHMRC project grant with A/Prof Julie McMullen for 2013-5 and had 9 publications during this time. I am now focussing on using systems biology to address underlying pathogenesis of cardiovascular disease for the remaining term of this fellowship. And just to make it more interesting, I have 73 samples of miRNA-seq data to analyse.My other collaborative projects can be viewed in Research Gate and ORCID and my publication can be viewed in NCBI PubMed and Google Scholar. I remain an active member of AGTA, HBPRCA and ASMR, as well as being part of the UNSW women in research network as a mentor. Written in Oct 2011.

Sydney, New South Wales (Nsw), Au

I was awarded a prestigious and named (top 5%) fellowship to conduct research into ageing and cardiovascular diseases. I was responsible for independent research, supervision of honors and PhD students, lab and grant management, systematic literature search and review, analysis of data generated, writing papers and grants and lecturing and present research outcomes. During this time, I held 1 NHMRC project grant; with A/P Liz Woodcock (2004-7) and was successful in securing another one with A/P Julie McMullen the following year (2009-11). Written in 2005, updated in 2009.

Melbourne, Vic, Au

An honorary position for building genomics communities in Australia and New Zealand. I remain an avid supporter of AGTA and I am involved in all the housekeeping matters of the Association including supporting the current president, secretary and treasurer as well as our annual meetings. We are heavily involved in conversations between academia, industry and government on all things genomics.

Melbourne, Vic, Au

Honorary position. Fostering and facilitating genomics in Australasia. Mentoring

Melbourne, Vic, Au

Australasian Genomic Technologies Association (AGTA), formerly AMATA is a multi-disciplinary professional and educational forum for the use of genomic and associated technologies. We are an integral part of the research community in the Australasian and the Pacific region and we provide support and discussion platform for researchers, industry professionals and students.As a recognition of my leadership in the genomics field in Australia, I served a 2-year term as the president of AGTA upon returning from my second maternity leave, and implemented equity and diversity initiatives to support 1) gender balance for invited speakers & session chairs and 2) delegates with carer responsibilities by having a parent room at AGTA’s annual meetings. Most importantly, my AGTA team contributed to the McKeon Review and the latest funding structural survey of NHMRC in Australia.

I started this company with my husband. MacLin Consulting mainly functions as an educational company providing effective services for IT issues, constructive advice for career development, career coaching and academic/medical writing. The business is run by word of mouth and serves the local community.

Sydney, Nsw, Au

Honorary position. Mentoring. Foster research and industry partnerships

Sydney, Nsw, Au

I had a brief glimpse into what consulting in healthcare is like as an industry. In this position, I was involved in systematic literature search and writing literature reviews. I also learnt the finer points of health technology assessment, MSAC and PBAC processes.

Sydney, Nsw, Au

My role as a senior research fellow at ADRI was introducing and integrating genomic technologies into their research projects. Following my track record, I utilised systems biology perspectives to uncover overlapping themes between cardiovascular diseases and mesothelioma. During my time at ADRI, I provided my expertise in writing grant applications and helped the Institute in securing a number of grants, equipment and research. For example: • 2016 Cancer Institute NSW, $412,567 (Hart et al. 2016/REG004, A high speed, multichannel fluorescence intravital microscope to provide state of the art imaging facilities essential to ANZAC/ADRI/Concord collaborative cancer research groups). • 2015 Slater & Gordon Health and Research Fund, $25,000 (Lin et al, circRNA – biomarker for Malignant Pleural Mesothelioma).• 2015 Cancer Institute NSW, $300,000 (Kao et al, ADRI Biobank).• 2015 Cancer Institute NSW, $385,470 (van Zandwijk, Reid, Lin et al, 15/REG/1-16).I also established many collaborations and assisted with writing of grants that utilised my expertise in experimental design, genomics and transcriptomics. For example:• 2016 CMT Association of Australia, $14,000 (Kennerson, Perez-Siles, Sapporta, Lin, Nicholson – Modelling a novel disease mechanism for distal hereditary motor neuropathy).• 2016 Philip Bushell Foundation, $75,000 (Kennerson, Perez-Siles, Sapporta, Lin – iPSC technologies to study hereditary neuropathy gene mutations).Publication list can be found at Google Scholar, Research Gate and ORCID.

Second maternity leave

As part of the NSW committee for ASMR, I was appointed the media contact for the annual ASMR meeting in Sydney. This involved being media savvy ie passing on correct scientific discovery to the media from individual ASMR associated scientists. I also chaired the professional development day in which the workshop is designed to help young researchers with their career decisions. I was a speaker for that workshop as part of the mentoring programme.

A new incorporated association established in 2003 to serve the research community in Australasia as a multi-disciplinary professional and educational forum for the use of microarrays and associated technologies, initially to now, encompassing all genomics technologies.I was responsible for AGTA's annual conference meetings, updating AGTA's backend website functionalities, payment gateway, contacting members and organising workshops in collaboration with various universities, biotechnology companies and medical institutes in Australia and New Zealand. During my presidency, 2013-2015, I lead the executive team to rewrite/edit AGTA's consitution in line with changes in genomic technologies, and implemented a new website.

Phd, Medicine (Molecular Genetics Of Hypertension)

Msc (Hons), Cellular & Molecular Biology

Bsc, Zoology And Chemistry

High School (Dux Of 1991)